Ampio Pharmaceuticals Inc (AMPE)
0.62
-0.09
(-12.92%)
USD |
NYAM |
Apr 12, 16:00
0.62
0.00 (0.00%)
After-Hours: 20:00
Ampio Pharmaceuticals Enterprise Value: -3.385M for April 12, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 12, 2024 | -3.385M |
| April 11, 2024 | -3.281M |
| April 10, 2024 | -3.124M |
| April 09, 2024 | -3.090M |
| April 08, 2024 | -3.078M |
| April 05, 2024 | -3.131M |
| April 04, 2024 | -3.135M |
| April 03, 2024 | -3.043M |
| April 02, 2024 | -3.181M |
| April 01, 2024 | -3.188M |
| March 28, 2024 | -3.044M |
| March 27, 2024 | -3.158M |
| March 26, 2024 | -3.168M |
| March 25, 2024 | -2.182M |
| March 22, 2024 | -2.193M |
| March 21, 2024 | -2.159M |
| March 20, 2024 | -2.250M |
| March 19, 2024 | -2.261M |
| March 18, 2024 | -2.182M |
| March 15, 2024 | -2.238M |
| March 14, 2024 | -2.227M |
| March 13, 2024 | -2.193M |
| March 12, 2024 | -2.136M |
| March 11, 2024 | -2.068M |
| March 08, 2024 | -2.244M |
| Date | Value |
|---|---|
| March 07, 2024 | -2.318M |
| March 06, 2024 | -2.318M |
| March 05, 2024 | -2.295M |
| March 04, 2024 | -2.295M |
| March 01, 2024 | -2.227M |
| February 29, 2024 | -2.329M |
| February 28, 2024 | -1.478M |
| February 27, 2024 | -2.000M |
| February 26, 2024 | -1.966M |
| February 23, 2024 | -2.023M |
| February 22, 2024 | -1.988M |
| February 21, 2024 | -1.886M |
| February 20, 2024 | -2.193M |
| February 16, 2024 | -2.148M |
| February 15, 2024 | -2.182M |
| February 14, 2024 | -2.023M |
| February 13, 2024 | -2.136M |
| February 12, 2024 | -2.170M |
| February 09, 2024 | -2.068M |
| February 08, 2024 | -2.091M |
| February 07, 2024 | -2.159M |
| February 06, 2024 | -2.159M |
| February 05, 2024 | -2.113M |
| February 02, 2024 | -2.057M |
| February 01, 2024 | -1.920M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.62M
Minimum
Dec 27 2022
501.43M
Maximum
Dec 22 2020
96.03M
Average
57.78M
Median
May 03 2019
Enterprise Value Benchmarks
| NeuBase Therapeutics Inc | -11.01M |
| Tivic Health Systems Inc | -1.774M |
| Oragenics Inc | 3.888M |
| Actinium Pharmaceuticals Inc | 171.43M |
| MAIA Biotechnology Inc | 33.66M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.054M |
| Total Expenses (Quarterly) | 2.215M |
| EPS Diluted (Quarterly) | -2.48 |
| Earnings Yield | -1.78K% |
| Normalized Earnings Yield | -30483.87 |